华润江中 (600750.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

15.8x

EV/EBITDA

10.9x

Market Cap

CNY 14.31B

MomentumView details →

1D Return

−8.53%

YTD Return

+1.17%

RSI (14)

43.6

ValuationView details →

P/E (Fwd)

15.8x

EV/EBITDA

10.9x

Market Cap

CNY 14.31B

RSI (14)

43.6

MomentumView details →

1D Return

−8.53%

YTD Return

+1.17%

ProfitabilityView details →

Gross Margin

65.24%

Net Margin

22.35%

EBITDA Margin

33.15%

ROE (TTM)

21.08%

ROA (TTM)

12.71%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

−6.31%

EPS YoY

+12.69%

FCF YoY

−10.07%

Revenue CAGR 3Y

+2.79%

EPS CAGR 3Y

+14.61%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.32

EPS Surprise

−16.12%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.28

Avg Surprise (4Q)

−16.12%

Rev Surprise

−2.40%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.86x

Quick Ratio

1.64x

Div Yield

5.89%

Div Rate

CNY 1.38

Div Growth 1Y

−26.67%

Financials snapshotView financials →

Revenue (TTM)

4.07B

Net Income (TTM)

909.82M

Op. CF (TTM)

826.05M

Next earningsOct 26, 2026 →

Latest newsMore news →

China Resources Jiangzhong announced its first-half 2026 results: net profit attributable to shareholders was 491 million yuan, down 5.92% year-on-year.15d ago

China Resources Jiangzhong proposed a cash dividend of 5 yuan per 10 shares, totaling 318 million yuan.15d ago

Similar companies

海正药业600267.SH 九洲药业603456.SH Fujian Haixi Pharmaceuticals Co., Ltd.02637.HK Neurocrine Biosciences, Inc.NBIX 步长制药603858.SH 健友股份603707.SH Find similar companies →

Latest newsMore news →

China Resources Jiangzhong announced its first-half 2026 results: net profit attributable to shareholders was 491 million yuan, down 5.92% year-on-year.15d ago China Resources Jiangzhong proposed a cash dividend of 5 yuan per 10 shares, totaling 318 million yuan.15d ago